miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. (Q39493576)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. |
scientific article |
Statements
1 reference
miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. (English)
1 reference
Fanfei Kong
1 reference
Chaoyang Sun
1 reference
Zhongxian Wang
1 reference
Lingfei Han
1 reference
Danhui Weng
1 reference
Yunping Lu
1 reference
Gang Chen
1 reference
7 August 2011
1 reference
31
1 reference
4
1 reference
543-549
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference